Expression and Significance of miR-106a and miR-24-1 in Colon Cancer
-
摘要: 目的 检测结肠癌与癌旁组织miR-106a和miR-24-1的表达差异及其与c-myc的表达是否具有关联性。方法选临床病理诊断明确的结肠癌患者，手术后取癌组织标本提取RNA，RT-PCR检测原癌基因c-myc在结肠癌组织与癌旁组织中的表达。TaqMan荧光定量PCR检测结肠癌与癌旁组织miR-106a和miR-24-1的表达差异。结果c-myc表达阳性的癌组织表达miR-106a要明显高于癌旁组织，其差异具有统计学意义（P<0.05）;c-myc表达阴性的癌组织表达miR-106a要高于癌旁组织（P<0.05），结肠癌组织与癌旁组织miR-24-1的表达无差异。结论结肠癌组织c-myc阳性组和c-myc阴性组表达miR-106a均高于癌旁组织，miR-106a有可能作为结肠癌的筛查目标之一；结肠癌组织c-myc阳性组和c-myc阴性组表达miR-24-1与癌旁组织无差异，还需更多研究证实其与结肠癌的关系。Abstract: Objective To investigate the expression of miR-106a and miR-24-1 in both colon cancer and adjacent tissues，and analyze the relationship between the expression of miR-106a，miR-24-1 and c-myc gene. Methods To extract RNA from colon cancer tissues and their adjacent ones，detected the mRNA expression of c-myc by RT-PCR.The TaqMan fluorescence quantitative PCR was used to analyze the expression of the miR-106a and miR-24-1 in both colon cancer and adjacent tissues. Results The results showed that the expression of miR-106a in cancer tissues was higher than that in the adjacent tissues in the c-myc positive group（P<0.05），and the expression of miR-106a in cancer tissues was also higher than that in the adjacent tissues in the c-myc negative ones(P<0.05).The expression of miR-24-1 showed no difference either between cancer and adjacent tissues，or between positive and negative c-myc control. Conclusion The expression of miR-106a in both c-myc positive group cancer tissues and the c-myc negative ones were higher than that in adjacent tissues.miR-106a might be a blood screening target of colon cancer.There was no difference of the expression of miR-24-1 in both the c-myc positive group ones and the c-myc negative ones，which need more research to prove the relation between miR-24-1 and colon cancer.
-
Key words:
- Colon cancer /
- miR-106a /
- miR-24-1 /
- c-myc
-
-
[1] Zhou H，Guo JM，Lou YR，et al.Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker [J].J Mol Med，2010，88(7):709-717. [2] He L，Hannon GJ.MicroRNAs: small RNAs with a big role in gene regulation [J].Nat Rev Genet，2004，5(7):522-531. [3] Kloosterman WP，Plasterk RH.The diverse functions of microRNAs in animal development and disease[J].Dev Cell，2006，11(4):441-450. [4] Perera RJ，Ray A.MicroRNAs in the search for understanding human diseases[J].Bio Drugs，2007，21(2):97-104. [5] Li QX，Huang YF，Wei YM，et al.Expression of stem cell-associated genes in colorectal cancer and SW620 cell line[J].Zhongguo Zu Zhi Gong Cheng Yan Jiu Yu Lin Chuang Kang Fu，2011，15(6):1015-1019.[李秋娴，黄颖烽，魏亚明，等.干细胞相关因子在大肠癌组织及SW620细胞株的表达[J].中国组织工程研究与临床康复，2011，15（6）：1015-1019.] [6] Habib T，Park H，Tsang M，et al.Myc stimulates B lymphocyte differentiation and amplifies calcium signaling[J].J Cell Biol，2007，179(4):717-731. [7] Wang Z，Liu M，Zhu H，et al.Suppression of p21 by c-myc through members of miR-17 family at the post-transcriptional level[J].Int J Oncol，2010，37(5):1315-1321. [8] Schetter AJ，Leung SY，Sohn JJ，et al.MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma[J].JAMA，2008，299(4): 425-436. [9] Sun F，Wang J，Pan Q，et al.Characterization of function and regulation of miR-24-1 and miR-31[J].Biochem Biophys Res Commun，2009，380(3): 660-665. [10] Zhao WY，Wang DD，Song MQ，et al.Role of microRNA-223 and its target gene oncogene c-myc in hepatocellular carcinoma pathogenesis[J].Zhonghua Gan Zang Bing Za Zhi，2011，19(2): 114-117.[赵文月，王冬冬，宋孟锜，等.微小RNA-223及其标靶基因c-myc在肝脏发病中的作用[J].中华肝脏病杂志，2011，19(2)：114-117.] [11] Kuppers DA，Hwang HC，Jackson AL，et al.Effect of Xpcl1 Activation and p27 Loss on Gene Expression in Murine Lymphoma[J].PLoS One，2011，6(3): e14758. [12] Lal A，Navarro F，Maher CA，et al.miR-24 Inhibits cell proliferation by targeting E2F2，MYC，and other cell-cycle genes via binding to “seedless” 3′UTR microRNA recognition elements[J].Mol Cell，2009，35(5): 610-625. [13] Xiao B，Guo J，Miao Y，et al.Detection of miR-106a in gastric carcinoma and its clinical significance[J].Clin Chim Acta，2009，400(1-2):97-102 [14] Tong AW，Nemunaitis J.Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy[J].Cancer Gene Ther，2008，15(6): 341-355. [15] Diaz R，Silva J，Garcia JM，et al.Deregulated expression of miR-106a predicts survival in human colon cancer patients[J].Genes Chromosomes Cancer，2008，47(9): 794-802.
计量
- 文章访问数: 2644
- HTML全文浏览量: 26
- PDF下载量: 639
下载:
